Trial intelligence / Profile preview

Melatonin for Quality of Life and Toxicity Reduction in Breast Cancer

NCT01557478Phase 3Unknown

Sponsor
Khon Kaen University
Start
Mar 2012
Primary completion
Sep 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of melatonin in breast cancer, sponsored by Khon Kaen University. Status: unknown.

02

Drugs

melatonin
03

Conditions

breast cancer

Beyond the preview

Go deeper on NCT01557478.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01557478.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call